Occlusive Medication with Imiquimod in Bowen's Disease [10]

Acta Dermato-Venereologica

Volumn 84, Issue 2, 2004, Pages 168-169

  Muzio, Gianfranco ^a   Ciambellotti, Aldo ^a   Rebora, Alfredo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IMIQUIMOD;

ADULT; AGED; BLEEDING; BOWEN DISEASE; CARCINOMA IN SITU; CASE REPORT; CREAM; DEPRESSION; DISEASE COURSE; ERYTHEMA; EXUDATE; FEMALE; FEVER; FLU LIKE SYNDROME; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; LETTER; MALE; OPEN STUDY; PRIORITY JOURNAL; PROTECTIVE CLOTHING; SKIN BIOPSY; SKIN ULCER; SQUAMOUS CELL CARCINOMA; WOUND DRESSING;

ADMINISTRATION, TOPICAL; AGED; AMINOQUINOLINES; BIOPSY, NEEDLE; BOWEN'S DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 1942540020     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550310006789     Document Type: Letter

References (11)

1. Eklind J, Maschke J, Lidbrink P, Hengge UR, Tartler U. Imiquimod to treat different cancers of the epidermis. Dermatol Surg 2003; 29: 890-896.
2. Smith KJ, Germain M, Skelton H. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg 2001; 27: 561-564.
3. Smith KJ, Germain M, Skelton H. Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a cox inhibitor, sulindac: potential applications for this combination of immunotherapy. Dermatol Surg 2001; 27: 143-146.
4. Mackenzie-Wood A, Kossard S, de Launey J, Wilkinson B, Owens ML. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol 2001; 44: 462-470.
5. Pehoushek J, Smith KJ. Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man. Arch Dermatol 2001; 137: 14-16.
6. Cook-Bolden F, Weinberg JM. Topical imiquimod 5% cream in the treatment of Bowen's disease of the penis. J Am Acad Dermatol 2002; 46: 146-147.
7. Schroeder TL, Sengelmann RD. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream. J Am Acad Dermatol 2002; 46: 545-548.
8. Gutzmer R, Kaspari M, Vogelbruch M, Kiehl P, Kapp A, Werfel T, et al. Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry. Br J Dermatol 2002; 147: 160-165.
9. Wu JK, Siller G, Whitehead K. Treatment of Bowen's disease and basal cell carcinoma of the nose with imiquimod 5% cream. Australas J Dermatol 2003; 44: 123-125.
10. Sterry W, Ruzicka T, Herrera E, Takwale A, Bichel J, Andres K, et al. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol 2002; 147: 1227-1236.
11. Bong AB, Bonnekoh B, Franke I, Schon MP, Ulrich J, Gollnick H. Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma. Dermatology 2002; 205: 135-138.